New CME/CE Activity for Oncology Care Providers
Driving Improved Outcomes in Resectable Melanoma Pathways for Optimized Adjuvant Immunotherapy Strategies
click here to learn more
CARE STEP PATHWAYS
These updates reflect the very latest management strategies for immune-related adverse event grading and management in 13 organ-specific working groups. Includes the addition of a Care Step Pathway for myocarditis.
LEARN MORE
New! Primer on Decision Making for Stage II Melanoma
The primer covers common questions about Stage II melanoma, which Stage II patients are eligible for adjuvant therapy, and the pros and cons of adjuvant therapy vs active surveillance.
This resource should help you or your loved one, in conjunction with your oncology care team, make an informed decision about steps to take after surgery.
LEARN MORE